---
title: "amfetamine - Attention deficit hyperactivity disorder"
sidebar: mydoc_sidebar
permalink: amfetamineattentiondeficithyperactivitydisorder.html
toc: false 
---

{% include image.html file="amfetamineattentiondeficithyperactivitydisorder.png" alt="amfetamineattentiondeficithyperactivitydisorder" %}![Path Visualization](/images/amfetamineattentiondeficithyperactivitydisorder.png)

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000661 | amfetamine | Drug |
| UniProt:Q05940 | monoamine transporter | Protein |
| MESH:D018377 | neurotransmitters | ChemicalSubstance |
| GO:0045202 | synapse | CellularComponent |
| MESH:D001289 | Attention deficit hyperactivity disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Amfetamine | DECREASES UPTAKE OF | Monoamine Transporter |
| Monoamine Transporter | INCREASES ABUNDANCE OF | Neurotransmitters |
| Neurotransmitters | LOCATED IN | Synapse |
| Synapse | NEGATIVELY CORRELATED WITH | Attention Deficit Hyperactivity Disorder |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB:DB00182#mechanism-of-action](https://go.drugbank.com/drugs/DB:DB00182#mechanism-of-action){:target="_blank"}